Shares Nautilus Biotechnology After a report showed that Amazon acquired the stake in the newly listed Seattle company, the stock price rose by 50% on Thursday morning.
Nautilus, founded in 2016 by the co-founders of Isilon Systems Suhar Patel And the Institute of Systems Biology alum Palag Malik, It is seeking to accelerate biomedical research and transform drug development by developing a new method to analyze the proteome (proteome in biological samples).
After the news came out, Nautilus’ stock price climbed from US$7.51 to US$11.30, and then trading in the stock was suspended. As of press time, the stock was 8.65, up 15% on the day.
Amazon has launched various healthcare plans in recent years, but it is unclear whether or how its Nautilus investments fit in with its own plans.
Bezos Expeditions, the venture capital arm of Amazon founder Jeff Bezos, is one of Nautilus investors, which merged with a special purpose acquisition company (SPAC) in June Listed.